| Date | Name | Title | Type | Shares Traded | Price Range | |||
|---|---|---|---|---|---|---|---|---|
| Mar 29, 2008 | vagelos p roy | Director | Disposition (Non Open Market) | 10,669 | n/a | |||
| Feb 27, 2008 | vagelos p roy | Director | Option Execute | 6,666 | 7.91 | |||
| Feb 20, 2008 | gilman alfred g | Director | Option Execute | 10,000 | 7.91 | |||
| Feb 15, 2008 | baker charles a | Director | Automatic Sell | 10,000 | 18.67 - 19.06 | |||
| Feb 15, 2008 | baker charles a | Director | Option Execute | 10,000 | 7.91 | |||
| Jan 22, 2008 | brown michael s | Director | Automatic Sell | 9,800 | 25.00 | |||
| Jan 22, 2008 | goldstein joseph l | Director | Automatic Sell | 5,000 | 25.00 | |||
| Jan 22, 2008 | goldstein joseph l | Director | Option Execute | 5,000 | 7.66 | |||
| Jan 17, 2008 | brown michael s | Director | Automatic Sell | 200 | 25.00 | |||
| Jan 3, 2008 | vagelos p roy | Director | Automatic Sell | 8,658 | n/a | |||
| Dec 24, 2007 | gilman alfred g | Director | Disposition (Non Open Market) | 500 | n/a | |||
| Dec 20, 2007 | sanofi-aventis | Beneficial Owner (10% or more) | Statement of Ownership | 0 | n/a | |||
| Dec 20, 2007 | schleifer leonard s | Officer | Automatic Sell | 22,207 | 22.28 | |||
| Dec 20, 2007 | schleifer leonard s | Officer | Option Execute | 37,370 | 8.63 | |||
| Dec 19, 2007 | gilman alfred g | Director | Disposition (Non Open Market) | 500 | n/a | |||
| Dec 17, 2007 | gilman alfred g | Director | Disposition (Non Open Market) | 1,500 | n/a | |||
| Dec 17, 2007 | goldberg murray a | Officer | Disposition (Non Open Market) | 200 | n/a | |||
| Dec 17, 2007 | yancopoulos george | Officer | Acquisition (Non Open Market) | 500,000 | n/a | |||
| Dec 12, 2007 | gilman alfred g | Director | Disposition (Non Open Market) | 2,000 | n/a | |||
| Nov 20, 2007 | roberts william | Officer | Acquisition (Non Open Market) | 34,684 | n/a | |||
| ||||||||
Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Stock Information
| NASDAQ:REGN
$24.60 + 0.18 |
Sep 9, 2010
4:00 PM ET |
Quotes delay at least 20min., by eSignal.
